In this trial Triphala(combination of three herbal drug)will be given to the overweight child to see its effect on weightless.

Evaluation of the Efficacy of Triphala Compound in Childhood Sthaulya-A Randomized,Double-blind,Placebo Controlled Clinical Trial - TRIOBESE

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013926

Enrollment

Registered

2018-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Obese Child with BMI 25-35,Age ranges from 10-14years

Interventions

Intervention1: triphala compound: 2 capsule(500mg capsule) thrice daily for 3 months Control Intervention1: placebo compound: wheat flour. Two capsule thrice daily for 3 months

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals having BMI >25(Overweight) and Grade 1 Obesity 2.Parents giving consent to participate in study.

Exclusion criteria

Exclusion criteria: 1.individual 14 year 2.Grade 2,3 & Super Obese & also obesity due to endocrinal diseases. 3.Patients with other co-morbid conditions & taking antiepileptic drugs or steroids. 4.Patients/Parents not willing to participate in study.

Design outcomes

Primary

Measure	Time frame
Response in BMITimepoint: After 3 months of drug interventions	—

Secondary

Measure	Time frame
Effect on general health parameters such as agni,ama etc.& also QoLTimepoint: After 6 months of drug interventions	—

Countries

India

Contacts

Public ContactMahapatra Arun Kumar

All India Institute of Ayurveda

srajagopala@gmail.com07600902564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026